Routine use of angiotensin-converting-enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs) is recommended in proteinuric nontransplant kidney disease patients, to reduce proteinuria and ...

Hypertension is typically treated with medications like diuretics, ACE inhibitors, beta-blockers, calcium channel blockers, ...

In a meta-analysis, investigators reviewed 127 randomized controlled trials in which ACE inhibitors or ARBs were compared with other antihypertensive agents or placebo for prevention of renal disease.

In addition to their capacity to lower systemic blood pressure, angiotensin-converting-enzyme (ACE) inhibitors and angiotensin-II receptor blockers (ARBs) are thought to have specific ...

According to the editorialists, these results trump prior results and should lead to elimination of ACE-I or ARB use for preserving kidney function in normotensive type 1 diabetic patients with ...

The message is that an early decrease in eGFR with finerenone should not lead to stopping the medication, say HF experts.

Glomerulonephritis (GN), a severe kidney condition impacting glomeruli, can lead to complications like high blood pressure, ...

Hypertension, also known as high blood pressure, is the most common cardiovascular risk factor. It describes a condition ...

High blood pressure, or hypertension, is a common condition that increases the risk of heart disease, stroke, and kidney ...

Background Acute kidney injury (AKI) in the context of acute decompensated heart failure (ADHF) encompasses a broad spectrum ...

This medication is an angiotensin-converting enzyme inhibitor (ACE inhibitor), prescribed for high blood pressure (hypertension), congestive heart failure, myocardial infarction and kidney ...